Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase)
1997

Study of a Mutation in the NQO1 Gene Related to Cancer

Sample size: 90 publication Evidence: moderate

Author Information

Author(s): RD Traver, D Siegel, HD Beaul, RM Phillips, NW Gibson, WA Franklin, D Ross

Primary Institution: University of Southern California School of Pharmacy and Kenneth Norris Jr. Comprehensive Cancer Center

Hypothesis

The mutation at position 609 of the NQO1 gene affects its enzymatic activity and has implications for cancer therapy.

Conclusion

The homozygous mutation at position 609 in the NQO1 gene leads to a complete loss of enzyme activity, which may impact cancer treatment and prevention.

Supporting Evidence

  • The study found a 7% incidence of individuals homozygous for the mutation in lung cancer samples.
  • Immunoblot analysis showed that the mutant NQO1 protein was not detectable in cells with the mutation.
  • Previous studies indicated that NQO1 activity is important for protection against certain carcinogens.

Takeaway

Some people have a change in a gene that stops it from working properly, which can make it harder for their bodies to fight cancer.

Methodology

The study involved sequencing the NQO1 gene in various cancer cell lines and analyzing the presence of a specific mutation using PCR and immunoblot techniques.

Limitations

The functional significance of the mutation and its occurrence in the population remains unclear.

Participant Demographics

The study included 45 lung cancer patients, predominantly Caucasian males aged 33 to 81.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication